CS

Chemplast Sanmar Ltd

Q3 FY26Chemicals & Petrochemicals

Chemplast Sanmar Ltd Q3 FY26 Results & Concall Highlights: Revenue, Margins & Order Book

Q3 FY26 earnings call: what management guided on revenue, margins and order book.

Price177
Market cap₹2.9K Cr
Updated23 Aug 2026
Read4 min read

The short version

R32 Plant: Targeting 14,000 tons capacity with phased commissioning; first full year revenue expected around INR 550 crores from ~11,000 tons production. The company is optimistic about sustainable growth ahead, supported by improving market sentiment, particularly in Suspension PVC.

From Chemplast Sanmar Ltd's Q3 FY26 earnings-call transcript · updated 23 Aug 2026.

Revenue & Sales Performance

  • R32 Plant: Targeting 14,000 tons capacity with phased commissioning; first full year revenue expected around INR 550 crores from ~11,000 tons production.
  • Custom Manufacturing Chemicals Division (CMCD): INR 1,000 crores revenue target by FY 2027-28, though delayed by 2-3 quarters due to ramp-up and market factors.
  • Suspension PVC: Demand expected to recover strongly in H2 FY 2026 after a flat first 9 months; breakeven expected by Feb-Mar at PBT level.
  • Paste PVC: Strong demand growth (~8% increase Y-o-Y in first 9 months) with recent price hikes; further margin improvements anticipated.
  • Overall: Company expects sustainable growth ahead driven by improving PVC market sentiment, ramp-up in specialty chemicals, and expansions, with no large capex planned beyond current projects.

Profitability & Margins

See what Chemplast Sanmar Ltd said on profitability & margins — free account, 30 seconds.

Capital Expenditure Plans

  • Current and future capex primarily includes the commissioning and expansion of the R32 plant and residual capex related to CMC (Custom Manufactured Chemicals) expansions.
  • The R32 plant expansion involves:
  • - Swing plant of 2,000 tons operational by end of current quarter.
  • - Additional 2,000-ton plant by Q1 next year.
  • - Last 10,000-ton plant by end of calendar year.
  • No large capex planned beyond these; the rest is mainly maintenance capex.
  • Details on maintenance capex and segment-wise capex can be provided offline.
  • New product development and CMC capex are on time despite some short-term agchem market slowdowns.
  • No current plans for equity fundraising; any future fundraising (equity or debt) will proceed as per project and operational requirements.

Top-ranked in Chemicals & Petrochemicals

Ranked on what management guided this quarter

5x potential
1Shiv Texchem
Rev 1Mar 2
2Yasho Industries
Rev 1Mar 3
3
Rev 1Mar 3
4
Rev 1Mar 3
5
Rev 2Mar 1
Sign up free to see 3 moreTakes 30 seconds · no cardSign up

Rank buckets describe management commentary on revenue and margin. Not investment advice, and not a forecast of returns.

Fundraising & Capital Structure

See what Chemplast Sanmar Ltd said on fundraising & capital structure — free account, 30 seconds.

Order Book & Pipeline

The transcript provided does not explicitly mention the current or expected order book or pending orders for Chemplast Sanmar Limited. However, some related insights include: - Custom Manufactured Chemicals (CMC) business: The pipeline remains strong with ongoing customer engagements and new product developments, though there is a delay in ramp-up due to agrochemical industry slowdown. Management remains confident of reaching INR 1,000 crores target by FY '27-'28. - For the R32 plant, commercial sales are expected to start post commissioning by end of the current quarter, with initial capacity largely targeted at the domestic market and export mix expected with full capacity. - No explicit mention of exact order book or pending orders figures in the call transcript. For detailed order book or pending order data, contacting the company or Investor Relations directly is recommended.

Chemplast Sanmar Ltd — Quarterly revenue & net profit

Revenue Net profit Net loss
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026

Reported quarterly figures (₹ Cr). Latest: revenue ₹1.3K Cr, net loss ₹45 Cr. Revenue and profit are scaled separately — hover a quarter for exact figures.

Full financials →

Others in Chemicals & Petrochemicals this season

  • Clean Science & Technology Ltd (Q3 FY26)

    Trade deal with Europe starting in FY '27 to potentially reduce tariffs (5.5%-12%), helping competitiveness against China. Key concall takeaways from Clean…

  • Aether Industries Ltd (Q3 FY26)

    The company currently services Baker Hughes with 8 products in commercial production (Site 4) generating a run rate of INR 60 crores this quarter. Key concall…

  • Kesar Petroproducts Ltd (Q3 FY26)

    Export markets constitute about 40% of sales, served through 7-8 distributors across geographies. Key concall takeaways from Kesar Petroprod.'s Q3 FY26…

  • Tata Chemicals Ltd (Q3 FY26)

    Indian salt capacity expansion of 210 KT per annum with INR 515 crore investment is underway to meet growing demand. Key concall takeaways from Tata…

🔎 Who's planning the most growth?

Companies ranked by management's own guidance — revenue, margins, capex and order book, from every earnings call in India.

See rankings →

Frequently Asked Questions

What were Chemplast Sanmar Ltd Q3 FY26 results?

R32 Plant: Targeting 14,000 tons capacity with phased commissioning; first full year revenue expected around INR 550 crores from ~11,000 tons production. The company is optimistic about sustainable growth ahead, supported by improving market sentiment, particularly in Suspension PVC.

What is Chemplast Sanmar Ltd share price analysis?

Chemplast Sanmar Ltd currently shows a neutral. The stock trades at a P/E of N/A with a market cap of ₹2,911 Cr. Investors should review the full earnings analysis for detailed insights.

Is Chemplast Sanmar Ltd planning capital expenditure?

Current and future capex primarily includes the commissioning and expansion of the R32 plant and residual capex related to CMC (Custom Manufactured Chemicals) expansions.

Keep Chemplast Sanmar Ltd on your radar — track it to get its next earnings analysis in your feed.

This analysis is AI-generated based on publicly available earnings data and concall transcripts. This is not investment advice. Please consult a SEBI-registered advisor before making investment decisions.